English

MINERVA SURGICAL INC

EDGAR

UTRS Quarterly report (10-Q) · filed 2023-11-13

12 filing records in this dataset, filed from 2021-09-27 to 2023-11-13. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

12 million USD

2023 Q3 · USD

Exact inputs and evidence

Revenue: 11965000 USD Source

Operating margin

-50.95%

2023 Q3 · %

Exact inputs and evidence

Operating Income: -6096000 USD Source
Revenue: 11965000 USD Source

Operating cash flow

-5.1 million USD

2023 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -23089000 USD Source
Operating Cash Flow: -17994000 USD Source

Free cash flow

-5.11 million USD

2023 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -23089000 USD Source
Operating Cash Flow: -17994000 USD Source
Capital Expenditure: 105000 USD Source
Capital Expenditure: 88000 USD Source

Cash and cash equivalents: 11.1 million USD 2023-09-30 Source
Exact value

11125000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 8.88 million shares 2023-09-30 Source
Exact value

8878582 shares

Reported share-count change

-69.35% · -20.1 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

28968185 shares · 2022-09-30· Source
8878582 shares · 2023-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

51.7 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Revenue: 50294000 USD · 2022-01-01 – 2022-12-31 Source
Revenue: 36490000 USD · 2022-01-01 – 2022-09-30 Source
Revenue: 12533000 USD · 2023-01-01 – 2023-03-31 Source
Revenue: 13391000 USD · 2023-04-01 – 2023-06-30 Source
Revenue: 11965000 USD · 2023-07-01 – 2023-09-30 Source

Net income

-33.5 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Net income: -34112000 USD · 2022-01-01 – 2022-12-31 Source
Net income: -27867000 USD · 2022-01-01 – 2022-09-30 Source
Net income: -11343000 USD · 2023-01-01 – 2023-03-31 Source
Net income: -8681000 USD · 2023-04-01 – 2023-06-30 Source
Net income: -7181000 USD · 2023-07-01 – 2023-09-30 Source

Operating cash flow

-38.7 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Operating cash flow: -35567000 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -19923000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -8386000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -17994000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -8386000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -23089000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -17994000 USD · 2023-01-01 – 2023-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-11-13.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2022-12-31
Operating income: 3 of 11 periods available· newest 2022-12-31
Net income: 3 of 11 periods available· newest 2022-12-31
Operating cash flow: 3 of 11 periods available· newest 2022-12-31
Capital expenditure: 3 of 11 periods available· newest 2022-12-31
Total assets: 3 of 11 periods available· newest 2022-12-31
Total liabilities: 3 of 11 periods available· newest 2022-12-31
Current assets: 3 of 11 periods available· newest 2022-12-31
Current liabilities: 3 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2022-12-31
long term debt: No compatible figures in this window
Shares outstanding: 3 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-3.5%

Prior period

USD 52.1 million

2021-01-01 – 2021-12-31
Current period

USD 50.29 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

50294000 − 52103000 = -1809000 USD

52103000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
50294000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MINERVA SURGICAL INC · 2022-12-31 MINERVA SURGICAL INC (edgar:1452965) Year-over-year change in Revenue: -1809000 USD Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: 0ebb2600257238ac2ef06374eae8871b6144b322e915cfecabe6c71a0143c57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452965?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 50294000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#2212987 Filing: 000095017023009186 Input fundies:Revenue: 52103000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#2214638 Filing: 000095017023009186
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 12.65 million

Prior period

−USD 21.46 million

2021-01-01 – 2021-12-31
Current period

−USD 34.11 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-34112000 − -21464000 = -12648000 USD

-21464000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-34112000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MINERVA SURGICAL INC · 2022-12-31 MINERVA SURGICAL INC (edgar:1452965) Year-over-year change in Net income: -12648000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: 0ebb2600257238ac2ef06374eae8871b6144b322e915cfecabe6c71a0143c57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452965?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -34112000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#3926893 Filing: 000095017023009186 Input fundies:NetIncome: -21464000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#3929060 Filing: 000095017023009186
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 13.19 million

Prior period

−USD 22.38 million

2021-01-01 – 2021-12-31
Current period

−USD 35.57 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-35567000 − -22379000 = -13188000 USD

-22379000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-35567000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · MINERVA SURGICAL INC · 2022-12-31 MINERVA SURGICAL INC (edgar:1452965) Year-over-year change in Operating cash flow: -13188000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: 0ebb2600257238ac2ef06374eae8871b6144b322e915cfecabe6c71a0143c57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452965?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -35567000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#2604075 Filing: 000095017023009186 Input fundies:OperatingCashFlow: -22379000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#2606188 Filing: 000095017023009186
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-87.5%

Prior period

USD 584,000

2021-01-01 – 2021-12-31
Current period

USD 73,000

2022-01-01 – 2022-12-31

Exact inputs and evidence

73000 − 584000 = -511000 USD

584000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
73000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · MINERVA SURGICAL INC · 2022-12-31 MINERVA SURGICAL INC (edgar:1452965) Year-over-year change in Capital expenditure: -511000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: 0ebb2600257238ac2ef06374eae8871b6144b322e915cfecabe6c71a0143c57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452965?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 73000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#2610981 Filing: 000095017023009186 Input fundies:CapitalExpenditure: 584000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#2613081 Filing: 000095017023009186
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 50.29 million 100% of revenue
Cost of revenue USD 23.05 million 46% of revenue
Operating expenses USD 58.14 million 116% of revenue
Operating income −USD 30.9 million −61% of revenue
Tax, interest and other Derived USD 3.21 million 6.4% of revenue
Net income −USD 34.11 million −68% of revenue

Cash

Operating cash flow −USD 35.57 million −71% of revenue
Capital expenditure USD 73,000 0.1% of revenue
Free cash flow Derived −USD 35.64 million −71% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Operating loss: operating costs were 141% of revenue.
2021 Operating loss: operating costs were 156% of revenue.
2022 Operating loss: operating costs were 161% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	37768000	53158000 Derived	-15390000	2873000 Derived	-18263000	-12694000 Derived	Source 2020-01-01 – 2020-12-31: 37768000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -15390000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -18263000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -12241000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 453000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	52103000	81248000 Derived	-29145000	-7681000 Derived	-21464000	-22963000 Derived	Source 2021-01-01 – 2021-12-31: 52103000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -29145000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -21464000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -22379000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 584000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	50294000	81193000 Derived	-30899000	3213000 Derived	-34112000	-35640000 Derived	Source 2022-01-01 – 2022-12-31: 50294000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -30899000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -34112000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -35567000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 73000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 50.3M 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Revenue	37768000	Revenue: 37768000 Open source
20212021-12-31	Revenue	52103000	Revenue: 52103000 Open source
20222022-12-31	Revenue	50294000	Revenue: 50294000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-3.5% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 37768000 Open source
20212021-12-31	Year over year	38%	Revenue: 52103000 Open source Revenue: 37768000 Open source
20222022-12-31	Year over year	-3.5%	Revenue: 50294000 Open source Revenue: 52103000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -61.4% 2022

Net margin -67.8% 2022

Free cash flow margin -70.9% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	-40.7%	Operating Income: -15390000 Open source Revenue: 37768000 Open source
20212021-12-31	Operating margin	-55.9%	Operating Income: -29145000 Open source Revenue: 52103000 Open source
20222022-12-31	Operating margin	-61.4%	Operating Income: -30899000 Open source Revenue: 50294000 Open source
20202020-12-31	Net margin	-48.4%	Net Income: -18263000 Open source Revenue: 37768000 Open source
20212021-12-31	Net margin	-41.2%	Net Income: -21464000 Open source Revenue: 52103000 Open source
20222022-12-31	Net margin	-67.8%	Net Income: -34112000 Open source Revenue: 50294000 Open source
20202020-12-31	Free cash flow margin	-33.6%	Revenue: 37768000 Open source Operating Cash Flow: -12241000 Open source Capital Expenditure: 453000 Open source
20212021-12-31	Free cash flow margin	-44.1%	Revenue: 52103000 Open source Operating Cash Flow: -22379000 Open source Capital Expenditure: 584000 Open source
20222022-12-31	Free cash flow margin	-70.9%	Revenue: 50294000 Open source Operating Cash Flow: -35567000 Open source Capital Expenditure: 73000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -35.6M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Operating cash flow	-12241000	Operating Cash Flow: -12241000 Open source
20212021-12-31	Operating cash flow	-22379000	Operating Cash Flow: -22379000 Open source
20222022-12-31	Operating cash flow	-35567000	Operating Cash Flow: -35567000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -35.6M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Free cash flow	-12694000	Operating Cash Flow: -12241000 Open source Capital Expenditure: 453000 Open source
20212021-12-31	Free cash flow	-22963000	Operating Cash Flow: -22379000 Open source Capital Expenditure: 584000 Open source
20222022-12-31	Free cash flow	-35640000	Operating Cash Flow: -35567000 Open source Capital Expenditure: 73000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

75.1% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Liabilities / assets	207.1%	Total Liabilities: 190602000 Open source Total Assets: 92046000 Open source
20212021-12-31	Liabilities / assets	61.7%	Total Liabilities: 70988000 Open source Total Assets: 115092000 Open source
20222022-12-31	Liabilities / assets	75.1%	Total Liabilities: 51719000 Open source Total Assets: 68900000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.53× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	1.37×	Current Assets: 45421000 Open source Current Liabilities: 33267000 Open source
20212021-12-31	Current assets / current liabilities	3.29×	Current Assets: 75004000 Open source Current Liabilities: 22809000 Open source
20222022-12-31	Current assets / current liabilities	2.53×	Current Assets: 36119000 Open source Current Liabilities: 14278000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−USD 18.26 million Exact value Exact value: -18263000 USD 2020-01-01 – 2020-12-31: -18263000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MINERVA SURGICAL INC · 2020-12-31 MINERVA SURGICAL INC (edgar:1452965) Net Income: -18263000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: 0ebb2600257238ac2ef06374eae8871b6144b322e915cfecabe6c71a0143c57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452965/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18263000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017022004333/utrs-20211231.htm#4783136 Filing: 000095017022004333 The citation records this snapshot. The page link may show a newer release later.	−USD 12.24 million Exact value Exact value: -12241000 USD 2020-01-01 – 2020-12-31: -12241000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MINERVA SURGICAL INC · 2020-12-31 MINERVA SURGICAL INC (edgar:1452965) Operating Cash Flow: -12241000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: 0ebb2600257238ac2ef06374eae8871b6144b322e915cfecabe6c71a0143c57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452965/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12241000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017022004333/utrs-20211231.htm#3364379 Filing: 000095017022004333 The citation records this snapshot. The page link may show a newer release later.	USD 453,000 Exact value Exact value: 453000 USD 2020-01-01 – 2020-12-31: 453000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MINERVA SURGICAL INC · 2020-12-31 MINERVA SURGICAL INC (edgar:1452965) Capital Expenditure: 453000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: 0ebb2600257238ac2ef06374eae8871b6144b322e915cfecabe6c71a0143c57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452965/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 453000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017022004333/utrs-20211231.htm#3374051 Filing: 000095017022004333 The citation records this snapshot. The page link may show a newer release later.	−USD 12.69 million Calculation and evidence -12241000 − 453000 USD Exact free cash flow: -12694000 USD 2020-01-01 – 2020-12-31: -12241000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 453000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MINERVA SURGICAL INC · 2020-12-31 MINERVA SURGICAL INC (edgar:1452965) Free cash flow: -12694000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: 0ebb2600257238ac2ef06374eae8871b6144b322e915cfecabe6c71a0143c57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452965?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12241000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017022004333/utrs-20211231.htm#3364379 Filing: 000095017022004333 Input fundies:CapitalExpenditure: 453000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017022004333/utrs-20211231.htm#3374051 Filing: 000095017022004333 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 21.46 million Exact value Exact value: -21464000 USD 2021-01-01 – 2021-12-31: -21464000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MINERVA SURGICAL INC · 2021-12-31 MINERVA SURGICAL INC (edgar:1452965) Net Income: -21464000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: 0ebb2600257238ac2ef06374eae8871b6144b322e915cfecabe6c71a0143c57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452965/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21464000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#3929060 Filing: 000095017023009186 The citation records this snapshot. The page link may show a newer release later.	−USD 22.38 million Exact value Exact value: -22379000 USD 2021-01-01 – 2021-12-31: -22379000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MINERVA SURGICAL INC · 2021-12-31 MINERVA SURGICAL INC (edgar:1452965) Operating Cash Flow: -22379000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: 0ebb2600257238ac2ef06374eae8871b6144b322e915cfecabe6c71a0143c57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452965/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22379000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#2606188 Filing: 000095017023009186 The citation records this snapshot. The page link may show a newer release later.	USD 584,000 Exact value Exact value: 584000 USD 2021-01-01 – 2021-12-31: 584000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MINERVA SURGICAL INC · 2021-12-31 MINERVA SURGICAL INC (edgar:1452965) Capital Expenditure: 584000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: 0ebb2600257238ac2ef06374eae8871b6144b322e915cfecabe6c71a0143c57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452965/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 584000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#2613081 Filing: 000095017023009186 The citation records this snapshot. The page link may show a newer release later.	−USD 22.96 million Calculation and evidence -22379000 − 584000 USD Exact free cash flow: -22963000 USD 2021-01-01 – 2021-12-31: -22379000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 584000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MINERVA SURGICAL INC · 2021-12-31 MINERVA SURGICAL INC (edgar:1452965) Free cash flow: -22963000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: 0ebb2600257238ac2ef06374eae8871b6144b322e915cfecabe6c71a0143c57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452965?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22379000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#2606188 Filing: 000095017023009186 Input fundies:CapitalExpenditure: 584000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#2613081 Filing: 000095017023009186 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 34.11 million Exact value Exact value: -34112000 USD 2022-01-01 – 2022-12-31: -34112000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MINERVA SURGICAL INC · 2022-12-31 MINERVA SURGICAL INC (edgar:1452965) Net Income: -34112000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: 0ebb2600257238ac2ef06374eae8871b6144b322e915cfecabe6c71a0143c57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452965/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34112000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#3926893 Filing: 000095017023009186 The citation records this snapshot. The page link may show a newer release later.	−USD 35.57 million Exact value Exact value: -35567000 USD 2022-01-01 – 2022-12-31: -35567000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MINERVA SURGICAL INC · 2022-12-31 MINERVA SURGICAL INC (edgar:1452965) Operating Cash Flow: -35567000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: 0ebb2600257238ac2ef06374eae8871b6144b322e915cfecabe6c71a0143c57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452965/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -35567000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#2604075 Filing: 000095017023009186 The citation records this snapshot. The page link may show a newer release later.	USD 73,000 Exact value Exact value: 73000 USD 2022-01-01 – 2022-12-31: 73000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MINERVA SURGICAL INC · 2022-12-31 MINERVA SURGICAL INC (edgar:1452965) Capital Expenditure: 73000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: 0ebb2600257238ac2ef06374eae8871b6144b322e915cfecabe6c71a0143c57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452965/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 73000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#2610981 Filing: 000095017023009186 The citation records this snapshot. The page link may show a newer release later.	−USD 35.64 million Calculation and evidence -35567000 − 73000 USD Exact free cash flow: -35640000 USD 2022-01-01 – 2022-12-31: -35567000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 73000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MINERVA SURGICAL INC · 2022-12-31 MINERVA SURGICAL INC (edgar:1452965) Free cash flow: -35640000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:59:26Z Snapshot: 0ebb2600257238ac2ef06374eae8871b6144b322e915cfecabe6c71a0143c57d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1452965?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -35567000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#2604075 Filing: 000095017023009186 Input fundies:CapitalExpenditure: 73000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1452965/000095017023009186/utrs-20221231.htm#2610981 Filing: 000095017023009186 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

12 filings · 911 latest values · 911 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001452965, 1452965, UTRS, edgar:1452965

Also known as MINERVA SURGICAL INC, MINERVA SURGICAL, INC.

MINERVA SURGICAL INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation